Systemic mitomycin C versus cisplatin: comparison of antitumor activity in primary murine bladder cancer

Stanley C. Hopkins, Robert Matheny, Mark S. Soloway

Research output: Contribution to journalArticle

1 Scopus citations

Abstract

The FANFT-induced bladder cancer murine model was used to evaluate the effect of DDP and MMC on the incidence and size of subsequent tumors. MMC was at least equally effective as DDP in inhibiting tumor growth in this model. There was no apparent synergistic effect when the two agents were combined although toxicity was increased. Further clinical trials with systemic MMC for locally advanced or metastatic urothelial transitional cell carcinoma appear to be indicated.

Original languageEnglish (US)
Pages (from-to)157-159
Number of pages3
JournalUrology
Volume20
Issue number2
DOIs
StatePublished - Aug 1982

ASJC Scopus subject areas

  • Urology

Fingerprint Dive into the research topics of 'Systemic mitomycin C versus cisplatin: comparison of antitumor activity in primary murine bladder cancer'. Together they form a unique fingerprint.

  • Cite this